Ophthalmology Innovation Summit

The Ophthalmology Innovation Summit (OIS)unites the leaders in the development of ophthalmic products, drugs, and devices. Meeting content is delivered by noted experts in academia, industry, and healthcare investing.

The Inaugural Summit attracted 407 delegates
from 25 US States and 11 countries

Ophthalmology Innovation Summit, 2009

407 delegates from 25 US States and 11 Countries

This Summit is immediately prior to the American Academy of Ophthalmology Convention

The audience includes: 400+-clinical and pre-clinical researchers, physicians/clinicians, university technology transfer officers, private and public company executives, corporate business development representatives, and investors.

Meeting Chair

Emmett T. Cunningham, Jr., MD, PhD, MPH →
Partner
Clarus Ventures, LLC

Meeting Co-Chairs

William J. Link, PhD →
Managing Director
Versant Ventures

Gil Kliman, MD →
Managing Director
InterWest Partners

Advisory Board Members

Anthony P. Adamis, MD →
Adjunct Professor of Ophthalmology & Visual Science - University of Illinois
Lecturer, Department of Ophthalmology, Harvard Medical School
VP, Global Head of Ophthalmology, Genentech

Mark S. Blumenkranz, MD →
Professor & Chairman - Department of Ophthalmology
Stanford University

Brook Byers →
Partner
Kleiner Perkins Caufield & Byers

Andy Corley →
Corporate VP & Global President Surgical Products
Bausch & Lomb

Eugene de Juan, MD →
Founder & Vice Chairman
ForSight Labs, LLC

David Guyer, MD →
Partner
SV Life Sciences

Richard L. Lindstrom, M.D.→
Founder & Attending Surgeon, Minnesota Eye Consultants,
Adjunct Professor Emeritus, and University of Minnesota Department of Ophthalmology

Sabri Markabi, MD →
Chief Medical Officer
Senior Vice President, R&D
Alcon Laboratories, Inc.

Jim Mazzo →
President, Abbott Medical Optics Inc.
Senior Vice President, Abbott Laboratories

Samir Patel, MD →
President & CEO
OphthoTech

Scott M. Whitcup, MD →
Executive Vice President, R&D and Chief Scientific Officer
Allergan

Presented by